We are live on ! Find out more
E

Ergoteles Portfolio holdings

AUM $68.2M
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+2.29%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
10 Year Est. Return
AUM
$2.85B
AUM Growth
-$497M
Cap. Flow
-$376M
Cap. Flow %
-13.23%
Top 10 Hldgs %
22.47%
Holding
2,268
New
669
Increased
298
Reduced
432
Closed
770

Sector Composition

Rank Sector Weight
1 Technology 20.43%
2 Financials 14.47%
3 Healthcare 11.04%
4 Real Estate 11%
5 Industrials 9.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRA icon
1376
Vera Bradley
VRA
$105M
$101K ﹤0.01%
33,400
-415,026
-93% -$1.67M
DECA
1377
DELISTED
Denali Capital Acquisition Corp. Class A Ordinary Shares
DECA
$101K ﹤0.01%
+10,000
New +$100K
PTWOU
1378
DELISTED
Pono Capital Two, Inc. Unit
PTWOU
$101K ﹤0.01%
+10,000
New +$100K
OCAX
1379
DELISTED
OCA Acquisition Corp. Class A Common Stock
OCAX
$101K ﹤0.01%
10,000
AMTI
1380
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$101K ﹤0.01%
103,547
-7,942
-7% -$14K
GGMCU
1381
DELISTED
Glenfarne Merger Corp. Unit
GGMCU
$101K ﹤0.01%
10,227
CND
1382
DELISTED
Concord Acquisition Corp.
CND
$101K ﹤0.01%
10,000
IVCAU
1383
DELISTED
Investcorp AI Acquisition Corp. Unit
IVCAU
$101K ﹤0.01%
10,010
GBBK
1384
DELISTED
Global Blockchain Acquisition Corp. Common Stock
GBBK
$100K ﹤0.01%
10,000
FSRXU
1385
DELISTED
FinServ Acquisition Corp. II Unit
FSRXU
$100K ﹤0.01%
10,200
ACRO
1386
DELISTED
Acropolis Infrastructure Acquisition Corp
ACRO
$99K ﹤0.01%
10,200
SDAC
1387
DELISTED
Sustainable Development Acquisition I Corp. Class A Common Stock
SDAC
$99K ﹤0.01%
+10,000
New +$98.5K
VTIQU
1388
DELISTED
VectoIQ Acquisition Corp. II Unit
VTIQU
$99K ﹤0.01%
+10,000
New +$98.5K
VINC
1389
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$98K ﹤0.01%
3,551
-484
-12% -$13.9K
ZLSWU
1390
DELISTED
Zalatoris II Acquisition Corp Unit
ZLSWU
$98K ﹤0.01%
+10,000
New +$98K
NGNE icon
1391
Neurogene
NGNE
$696M
$97K ﹤0.01%
7,566
-732
-9% -$14.9K
OSUR icon
1392
OraSure Technologies
OSUR
$273M
$97K ﹤0.01%
+25,676
New +$92.8K
TWO
1393
Two Harbors Investment
TWO
$1.27B
$96K ﹤0.01%
+7,238
New +$141K
PASG icon
1394
Passage Bio
PASG
$15.9M
$95K ﹤0.01%
3,803
-4,614
-55% -$182K
SLDB icon
1395
Solid Biosciences
SLDB
$771M
$95K ﹤0.01%
13,618
-3,442
-20% -$34.7K
ASTS icon
1396
AST SpaceMobile
ASTS
$16.8B
$91K ﹤0.01%
12,600
-185,267
-94% -$1.63M
ONCT
1397
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$90K ﹤0.01%
5,030
-5,629
-53% -$121K
CRIS icon
1398
Curis
CRIS
$9.53M
$87K ﹤0.01%
311
-1,184
-79% -$477K
VIRC icon
1399
Virco
VIRC
$94.4M
$86K ﹤0.01%
20,212
-400
-2% -$1.66K
BDTX icon
1400
Black Diamond Therapeutics
BDTX
$101M
$85K ﹤0.01%
50,347
-59,653
-54% -$184K

Similar funds

Ergoteles's Q3 2022 Portfolio in Review

As of Q3 2022, Ergoteles held 2,268 positions worth $2.85B, down 15% from $3.34B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Ergoteles withdrew a net $376M in Q3 2022, closing 770 positions and reducing 432 holdings. Its most notable exit was Yum China, an estimated $40.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ergoteles opened a new position in Morgan Stanley worth $41.5M.

  • Ergoteles's largest Q3 2022 buy was Morgan Stanley: 525,381 shares worth $41.5M.
  • Ergoteles added most to Duke Realty Corp. in Q3 2022, an estimated $174M increase.
  • Ergoteles's biggest Q3 2022 reduction was State Street Technology Select Sector SPDR ETF, cutting an estimated $79.9M.
  • Ergoteles fully exited Yum China in Q3 2022, selling an estimated $40.8M.
  • Ergoteles's ten largest holdings make up 22% of its $2.85B portfolio in Q3 2022.
  • Ergoteles opened 669 new positions and closed 770 in Q3 2022.
  • Ergoteles's portfolio value fell 15% quarter-over-quarter to $2.85B.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.